Pennsylvania Opioid Fee Fund Home

Welcome to the official website of the Pennsylvania Opioid Fee Fund. This website has been established to provide information to eligible counsel on the application and reimbursement procedures for the Pennsylvania Opioid Fee Fund created by the Pennsylvania Opioids Trust and Allocation Order entered by the Commonwealth Court of Pennsylvania in Commonwealth ex re. Josh Shapiro v. AmerisourceBergen Corp., et al.  

Pursuant to the August 2, 2022 Order Granting Plaintiffs’ Motion to Establish a Pennsylvania Opioid Fee Fund and Appoint a Special Master to Determine and Disburse Attorneys’ Fees and Establish a Procedure for Reimbursing Counsel for Documented Expenses and Costs (collectively the “Fee Fund Orders”), the Special Master is responsible for designing and implementing processes and procedures for the allocation of contingency fees, Agreed Litigation Conduct fees, and the reimbursement of costs and expenses.

Pursuant to the Court’s November 13, 2024 Order Granting Plaintiffs’ Motion to Add Funds to the Pennsylvania Opioid Fee Fund and consistent with the terms of the Trust and pursuant to 42 P.S. § 2503(8), the WAVE 2 Settlement attorney fees and costs will be disbursed by the Pennsylvania Opioid Fee Fund established by Order of this Court on August 2, 2022.

ORDERS

1. (August 2, 2022) Order Granting Plaintiffs’ Motion to Establish a Pennsylvania Opioid Fee Fund and Appoint a Special Master to Determine and Disburse Attorneys’ Fees and Establish a Procedure for Reimbursing Counsel for Documented Expenses and Costs

2. (August 31, 2022) Order Setting Deadline to Serve Executed Intent to Participate In Pennsylvania Opioid Fee Fund Form

3. (September 14, 2022) Order Establishing Application Protocols for Reimbursement of Costs and Expenses Under the Pennsylvania Opioids Trust and Allocation Order

4. (December 13, 2022) Special Master’s Report and Recommendation of Final Awards for Reimbursement of Contract Attorney and Other Eligible Costs and Expenses From the Commonwealth of Pennsylvania’s Opioid Misuse and Addiction Abatement Trust and the Pennsylvania Opioid Fee Fund

5. (December 15, 2022) Order Approving and Adopting the Special Master’s Report and Recommendation of Final Awards for Reimbursement of Contract Attorney and Other Eligible Costs and Expenses From the Commonwealth of Pennsylvania’s Opioid Misuse and Addiction Abatement Trust and the Pennsylvania Opioid Fee Fund

6. (January 30, 2023) Special Master’s First Semi-Annual Report Through December 31, 2022 Regarding the Deposits, Expenditures, and Payments To and From the Commonwealth of Pennsylvania’s Opioid Fee Fund

7. (February 17, 2023) Order Establishing Application Protocols for Allocation and Payment of Contingency and Agreed Litigation Conduct (A/K/A Common Benefit) Fees Under the Pennsylvania Opioids Trust and Allocation Order

8. (February 24, 2023) Fee Panel Order No. 21 Regarding Contingent Fees in Pennsylvania Cases

9. (July 24, 2023) Special Master’s Second Semi Annual Report for the Time Period of January 1, 2023 to June 30, 2023 Regarding the Deposits, Expenditures and Payments to and From the Commonwealth of Pennsylvania’s Opioid Fee Fund

10. (December 6, 2023) Application of Special Master Judge Joel Schneider (Ret.) for Court Approval of the Final Contingency Fee Awards

11. (December 14, 2023) Order Approving Final Contingency Fee Awards

12. (January 29, 2024) Special Master’s Report and Recommendation on the Allocation of Agreed Litigation Conduct (A/K/A Common Benefit) Fees

13. (February 14, 2024) Special Master’s Third Semi-Annual Report for the Time Period of July 1, 2023 to December 31, 2023 Regarding the Deposits, Expenditures and Payments to and From the Commonwealth of Pennsylvania’s Opioid Fee Fund

14. (February 15, 2024) Application of Special Master Judge Joel Schneider (Ret.) for Court Approval of the Final Agreed Litigation Conduct (A/K/A Common Benefit) Fee Awards

15. (February 16, 2024) Order Approving Final Agreed Litigation Conduct (A/K/A Common Benefit) Fee Awards

16. (June 28, 2024) Special Master’s Fourth Semi-Annual Report for the Time Period of January 1, 2024 to June 30, 2024 Regarding Deposits, Expenditures and Payments to and From the Commonweath of Pennsylvania’s Opioid Fee Fund

17. (January 28, 2025) Special Master’s Fifth Semi-Annual Report covering the time period July 1, 2024 through December 31, 2024 Regarding Deposits, Expenditures and Payments to and from the Commonwealth of Pennsylvania’s Opioid Fee Fund

18. (August 6, 2025) Special Master’s Sixth Semi-Annual Report for the Time Period of January 1, 2025 to June 30, 2025 Regarding the Deposits, Expenditures and Payments to and From the Commonwealth of Pennsylvania’s Opioid Fee Fund

19. (November 13, 2024) Order Granting Plaintiffs’ Motion to Add Funds to the Pennsylvania Opioid Fee Fund

20. (September 16, 2025) Order Establishing Application Protocols for the Reimbursement of Costs and Expenses and the Allocation and Payment of Agreed Litigation Conduct (“Common Benefit”) and Contingency Fees Under the First Amended and Restated Pennsylvania Opioids Trust and Allocation Order for Wave 2 Settlements

Click on the links below to access application information for each of the following:

Costs & Expenses (Contract Attorney and other Eligible Costs & Expenses)

Contingency Fees

Agreed Litigation Conduct (Common Benefit) Fees

CURRENT DEADLINES

October 17, 2025 – Submit Costs & Expenses application via Rubris Crosslink

October 17, 2025 – Submit contingency fee fund application via Rubris Crosslink

November 17, 2025 – Submit Common Benefit Fee Application vis Rubris Crosslink